Head-To-Head Comparison: Haemonetics (HAE) vs. Restoration Robotics (NASDAQ:HAIR)

Restoration Robotics (NASDAQ:HAIR) and Haemonetics (NYSE:HAE) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, analyst recommendations and valuation.

Earnings and Valuation

This table compares Restoration Robotics and Haemonetics’ revenue, earnings per share and valuation.

Haemonetics has higher revenue and earnings than Restoration Robotics. Restoration Robotics is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent ratings for Restoration Robotics and Haemonetics, as provided by MarketBeat.

Restoration Robotics currently has a consensus price target of $2.62, suggesting a potential upside of 295.77%. Haemonetics has a consensus price target of $119.00, suggesting a potential upside of 40.80%. Given Restoration Robotics’ higher possible upside, research analysts plainly believe Restoration Robotics is more favorable than Haemonetics.

Insider and Institutional Ownership

27.8% of Restoration Robotics shares are owned by institutional investors. Comparatively, 98.1% of Haemonetics shares are owned by institutional investors. 37.8% of Restoration Robotics shares are owned by company insiders. Comparatively, 1.0% of Haemonetics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Volatility and Risk

Restoration Robotics has a beta of 4.91, meaning that its share price is 391% more volatile than the S&P 500. Comparatively, Haemonetics has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500.

Profitability

This table compares Restoration Robotics and Haemonetics’ net margins, return on equity and return on assets.

Summary

Haemonetics beats Restoration Robotics on 11 of the 14 factors compared between the two stocks.

About Restoration Robotics

Restoration Robotics, Inc., a medical device company, develops and commercializes image-guided robotic systems in the United States and internationally. The company offers ARTAS System, a physician-assisted robotic system that identifies and dissects hair follicular units directly from the scalp and creates recipient implant sites. Its system includes the ARTAS Hair Studio application, an interactive three-dimensional patient consultation tool that enables a physician to create a simulated hair transplant model for use in patient consultations. The company was founded in 2002 and is headquartered in San Jose, California.

About Haemonetics

Haemonetics Corporation, a healthcare company, provides hematology products and solutions. The company operates through five segments: North America Plasma; Americas Blood Center and Hospital; Europe, Middle East and Africa; Asia Pacific; and Japan. It offers automated plasma collection devices and related disposables, including NexSys PCS plasmapheresis system and PCS2 equipment and disposables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. The company also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx and El-Dorado Donor donation and blood unit management systems; Hemasphere software that provides support for blood drive planning; and Donor Doc and e-Donor software to enhance the donor recruitment and retention. In addition, it offers hospital products comprising TEG diagnostic systems that enables clinicians to assess the coagulation status of a patient at the point-of-care or laboratory setting; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; Cell Saver Elite +, a surgical blood salvage system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; OrthoPAT, a perioperative autotranfusion system for orthopedic procedures; and BloodTrack, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital’s blood bank information system. Haemonetics Corporation was founded in 1971 and is headquartered in Braintree, Massachusetts.

Receive News & Ratings for Restoration Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Restoration Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.